Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
This study elucidated the clinical, humoral immune response and genomic analysis of vaccine breakthrough (VBT) infections after ChAdOx1 nCoV-19/Covishield vaccine in healthcare workers (HCWs). Amongst 1858 HCWs, 1639 had received either two doses (1346) or a single dose (293) of ChAdOx1 nCoV-19 vaccine. SARS-CoV-2 IgG antibodies and neutralizing antibodies were measured in the vaccinated group and the development of SARS-CoV-2 infection was monitored.Forty-six RT-PCR positive samples from the 203 positive samples were subjected to whole genome sequencing (WGS). Of the 203 (10.92%) infected HCWs, 21.46% (47/219) were non-vaccinated, which was significantly more than 9.52% (156/1639) who were vaccinated and infection was higher in doctors and nurses. Unvaccinated HCWs had 1.57 times higher risk compared to partially vaccinated HCWs and 2.49 times higher risk than those who were fully vaccinated.The partially vaccinated were at higher risk than the fully vaccinated (RR 1.58). Antibody non-response was seen in 3.44% (4/116), low antibody levels in 15.51% (18/116) and medium levels were found in 81.03% (94/116). Fully vaccinated HCWs had a higher antibody response at day 42 than those who were partially vaccinated (8.96 + 4.00 vs. 7.17 + 3.82). Whole genome sequencing of 46 samples revealed that the Delta variant (B.1.617.2) was predominant (69.5%). HCWs who had received two doses of vaccine showed better protection from mild, moderate, or severe infection, with a higher humoral immune response than those who had received a single dose. The genomic analysis revealed the predominance of the Delta variant (B.1.617.2) in the VBT infections.
Article activity feed
-
-
SciScore for 10.1101/2021.06.28.21259546: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IACUC: The study had the approval of the Institutional Ethical Committee (IEC/2020/77/MA07) and was conducted following the Declaration of Helsinki. Sex as a biological variable not detected. Randomization SARS-CoV-2 Whole genome sequencing: Sequencing using Illumina MiSeq Platform: 46 RT-PCR positive samples (Ct value ≤ 20) were randomly selected from the Virology repository at -80°C and subjected to whole genome sequencing (WGS). Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources The SARS COV2 IgG antibodies were measured using the enhanced chemiluminescence method (Vitros ECi, Ortho Clinical Diagnostics, New Jersey, US). SARS COV2 IgGsuggested: …SciScore for 10.1101/2021.06.28.21259546: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IACUC: The study had the approval of the Institutional Ethical Committee (IEC/2020/77/MA07) and was conducted following the Declaration of Helsinki. Sex as a biological variable not detected. Randomization SARS-CoV-2 Whole genome sequencing: Sequencing using Illumina MiSeq Platform: 46 RT-PCR positive samples (Ct value ≤ 20) were randomly selected from the Virology repository at -80°C and subjected to whole genome sequencing (WGS). Blinding not detected. Power Analysis not detected. Table 2: Resources
Antibodies Sentences Resources The SARS COV2 IgG antibodies were measured using the enhanced chemiluminescence method (Vitros ECi, Ortho Clinical Diagnostics, New Jersey, US). SARS COV2 IgGsuggested: (EnCor Biotechnology Cat# RPCA-SARS-CoV2-bd, RRID:AB_2861175)Software and Algorithms Sentences Resources SARS-CoV-2 Whole genome sequencing: Sequencing using Illumina MiSeq Platform: 46 RT-PCR positive samples (Ct value ≤ 20) were randomly selected from the Virology repository at -80°C and subjected to whole genome sequencing (WGS). WGSsuggested: NoneSequencing data analysis: MiSeq data analysis: FastQC v0.11.9 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) was used to check the Phred quality score for all sequences. MiSeqsuggested: (A5-miseq, RRID:SCR_012148)FastQCsuggested: (FastQC, RRID:SCR_014583)Phredsuggested: (Phred, RRID:SCR_001017)Adapter trimming was performed using the Trim Galore tool v0.6.1 (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and alignment of sequences was performed using the HISAT2 [7] algorithm on human data build GRCh38. Trim Galoresuggested: (Trim Galore, RRID:SCR_011847)HISAT2suggested: (HISAT2, RRID:SCR_015530)To remove any human sequences from the dataset, samtools v1.12 [8] were used to remove aligned sequences. samtoolssuggested: (SAMTOOLS, RRID:SCR_002105)SARS-CoV-2 Phylogenetic and mutation analysis: We sequenced 46 vaccinated COVID-19 positive samples that were aligned to NC_045512 reference genome using MAFFT v7.475 [9] multiple alignment tool. MAFFTsuggested: (MAFFT, RRID:SCR_011811)The aligned sequences were trimmed to remove gaps and a phylogenetic tree was generated using the default model of the IQ-TREE tool v2.0.3 [10]. IQ-TREEsuggested: (IQ-TREE, RRID:SCR_017254)The tree was visualized using FigTree v1.4.4 [11]. FigTreesuggested: (FigTree, RRID:SCR_008515)The lollipop plot is generated in RStudio using g3viz, rtracklayer, and trackViewer packages followed by data visualization using the ggplot2 package. RStudiosuggested: (RStudio, RRID:SCR_000432)ggplot2suggested: (ggplot2, RRID:SCR_014601)All the figures were updated using Inkscape software [13]. Inkscapesuggested: (Inkscape, RRID:SCR_014479)The statistical analysis was done using SPSS software version 22. SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-